FDA Pulls Heartburn Drug Zantac From Market

WEDNESDAY, April 1, 2020 -- All versions of the heartburn drug Zantac (ranitidine) have been pulled from the U.S. market due to possible contamination with a probable human carcinogen, the U.S. Food and Drug Administration said Wednesday. This is...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news